Skip to main content
SUNFLOWER PHARMACEUTICAL GROUP CO.,LTD logo

SUNFLOWER PHARMACEUTICAL GROUP CO.,LTD — Investor Relations & Filings

Ticker · 002737 ISIN · CNE100001WT7 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,262 across all filing types
Latest filing 2022-10-26 Board/Management Inform…
Country CN China
Listing Shenzhen Stock Exchange 002737

About SUNFLOWER PHARMACEUTICAL GROUP CO.,LTD

https://www.kuihuayaoye.com

Sunflower Pharmaceutical Group Co., Ltd. focuses on the research, development, manufacturing, and distribution of proprietary Chinese medicines, chemical drugs, and health supplements. The organization is particularly noted for its specialization in pediatric medicine, marketed under the "Little Sunflower" brand, which includes treatments for respiratory and digestive ailments. Its extensive product portfolio also covers gynecological health and general internal medicine. The group operates several integrated production bases and research institutes, facilitating a comprehensive approach to drug formulation and quality control. By leveraging a robust supply chain and a wide-reaching distribution network, the company provides a diverse range of over-the-counter and prescription solutions aimed at improving family health and wellness.

Recent filings

Filing Released Lang Actions
董事会决议公告
Board/Management Information Classification · 95% confidence The document is a board meeting resolution announcement from a company's board of directors. It specifically mentions the approval of the company's 2022 third quarter report and its disclosure to the public. The document is short (735 characters) and serves as an announcement of the board meeting decisions rather than the full quarterly report itself. It does not contain detailed financial statements or substantive financial data, only the approval and disclosure statement. Therefore, it is best classified as a Board/Management Information (MANG) filing, which covers announcements of board decisions and management information.
2022-10-26 Chinese
监事会决议公告
Regulatory Filings Classification · 95% confidence The document is a formal announcement of the supervisory board's resolution regarding the review and approval of the company's 2022 third quarter report. It states that the supervisory board has reviewed the procedures and content of the quarterly report and found them compliant and accurate. The document is short (670 characters) and primarily serves as a meeting resolution announcement rather than containing the actual financial data or the full quarterly report itself. It does not contain detailed financial statements or substantive analysis, but rather confirms the approval of the report. Therefore, it is best classified as a Regulatory Filing (RNS) because it is an official announcement related to regulatory compliance and internal governance, but not the report itself.
2022-10-26 Chinese
2022年三季度报告
Interim / Quarterly Report Classification · 100% confidence The document is titled as the "2022 Third Quarter Report" of 葵花药业集团股份有限公司, indicating it is a quarterly financial report. It contains detailed financial statements including balance sheet, income statement, and cash flow statement for the third quarter ending September 30, 2022. The report explicitly states it is unaudited and includes comprehensive financial data and analysis for the quarter. This matches the definition of an Interim / Quarterly Report (IR), which must contain actual financial statements and substantive financial data for a period shorter than a full fiscal year. The document length (13,277 characters) and content confirm it is the full report, not just an announcement or summary. Therefore, the correct classification is IR with high confidence. 9M 2022
2022-10-26 Chinese
关于为子公司提供担保的进展公告
Capital/Financing Update Classification · 95% confidence The document is a public announcement from a company regarding the progress of providing guarantees for its subsidiary. It details the guarantee amount, the contractual agreement with a bank, the scope and duration of the guarantee, and the total amount of guarantees provided. There is no financial statement, earnings data, or detailed report content. The document is relatively short (1364 characters) and serves as an update on a specific financing-related activity (providing guarantees). This fits best under Capital/Financing Update (CAP) as it relates to financing activities and guarantees provided by the company for its subsidiaries.
2022-09-23 Chinese
关于使用闲置自有资金进行现金管理的进展公告
Capital/Financing Update Classification · 95% confidence The document is a public announcement by a company regarding the progress of using idle funds for cash management, including details of financial products purchased, risk control measures, and impact on the company. It is not a full financial report, earnings release, or management discussion. It is a regulatory announcement about financing activities related to cash management and investment of idle funds. The document length is about 5,531 characters, which is sufficient for a detailed announcement but does not contain comprehensive financial statements or analysis. Therefore, it fits best under Capital/Financing Update (CAP) as it updates on the company's financing activities and capital usage.
2022-09-19 Chinese
2022年第二次临时股东大会的法律意见
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a legal opinion issued by a law firm regarding the convening, procedures, and voting results of a specific shareholders' meeting (the 2022 second extraordinary general meeting) of a company. It details the legality of the meeting's call, attendance, voting process, and results. It does not contain financial statements or financial performance data, nor is it a report of financial results or management discussion. It is not an announcement of a report but a legal opinion related to a shareholders' meeting. This type of document is best classified under Declaration of Voting Results & Voting Rights Announcements (DVA), as it provides official confirmation and legal opinion on the voting results and procedures of a shareholders' meeting.
2022-09-09 Chinese

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.